Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

26 trials with published results (15%)

Research Maturity

101 completed trials (56% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.3%

13 terminated out of 179 trials

Success Rate

88.6%

+2.0% vs benchmark

Late-Stage Pipeline

11%

19 trials in Phase 3/4

Results Transparency

26%

26 of 101 completed with results

Key Signals

26 with results89% success13 terminated

Data Visualizations

Phase Distribution

114Total
Not Applicable (47)
Early P 1 (3)
P 1 (21)
P 2 (24)
P 3 (13)
P 4 (6)

Trial Status

Completed101
Recruiting26
Unknown25
Terminated13
Active Not Recruiting9
Withdrawn3

Trial Success Rate

88.6%

Benchmark: 86.6%

Based on 101 completed trials

Clinical Trials (179)

Showing 20 of 20 trials
NCT00655096RecruitingPrimary

Screening for Research Participants

NCT05276063Phase 2Completed

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

NCT04663750Phase 3RecruitingPrimary

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

NCT06177639CompletedPrimary

Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging

NCT07174687Phase 2Recruiting

SGLT2 Inhibitors in Geographic Atrophy

NCT02317328RecruitingPrimary

Adaptive Optics Retinal Imaging

NCT04127006Completed

Rate of Progression in EYS Related Retinal Degeneration

NCT07413172Phase 2Recruiting

Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye

NCT06891443Phase 3Recruiting

Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

NCT05851287Recruiting

The Proactive Ophthalmic Examination Cohort

NCT06455826Phase 1Completed

MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)

NCT02710916Not ApplicableCompleted

SD-OCT Multimodal Analysis in GLaucoma

NCT05656027Phase 3Completed

Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia

NCT05753189Phase 3Completed

Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia Subjects

NCT07228793Recruiting

Natural History Study of Patients With EYS-Associated RP

NCT04289909Not ApplicableCompleted

Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)

NCT04232982Not ApplicableRecruiting

The Role of Transscleral Cyclophotocoagulation in Patients Undergoing a Boston Keratoprosthesis

NCT06399211CompletedPrimary

Investigation of the Safety and Effectiveness of Monofocal Toric Intraocular Lens (IOL)

NCT07322302Not ApplicableRecruiting

RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)

NCT06841575Not ApplicableRecruitingPrimary

Advancing Pediatric Retinal Imaging With Auto-aligned OCT

Scroll to load more

Research Network

Activity Timeline